Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss a Randomized Controlled Trial
-
- STATUS
- Recruiting
-
- participants needed
- 18
-
- sponsor
- Tan Tock Seng Hospital
Summary
This is a randomized controlled trial to compare intra-gastric injection of Botulinum Toxin A (Botox; Allergan Inc. Irvine, Ca, USA) against non-surgical management for obesity (i.e. exercise/diet). Our hypothesis is that intra-gastric injection of Botox into the fundus and body of the stomach will result in greater weight loss than just exercise and diet alone.
Details
Condition | Weight Loss, Weight Loss, Obesity, Obesity |
---|---|
Age | 21years - 65years |
Treatment | Botulinum toxin type A, Weight Management Program |
Clinical Study Identifier | NCT04274608 |
Sponsor | Tan Tock Seng Hospital |
Last Modified on | 16 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.